In short. The questions that separate a study finding from a marketing sentence, where each kind of claim usually appears, and how to check one for yourself.

Key points

  • Findings appear in studies, in regulatory documents and in guidance from professional bodies.
  • Sentences about findings appear in material that has an interest in a conclusion.
  • That does not make the second kind false, and it does mean the second kind is where checking pays off, because it is where a careful finding is most often stretched.

The most useful skill in this subject is not knowing the evidence. It is being able to tell, in a few seconds, whether a sentence is a finding or a claim. Both kinds are written in the same confident register, both appear in professional-looking material, and the difference between them is not visible in the sentence itself. It is visible in what stands behind it.

Four questions that do most of the work

The first is what kind of study the sentence comes from, and whether that design can support the claim being made from it. A registry can show that two things occur together; it cannot show that one causes the other, so a causal sentence attributed to a registry has already failed. The second is who was studied, for how long, and how complete the follow-up was, because a finding in a small group followed briefly is a weaker statement than the same sentence suggests. The third is whether the sentence describes a finding or describes the absence of one as though it were a finding. The fourth is who paid for the work and who is repeating it.

Reading the summary against the study

Where a claim is attributed to research, the gap between the study and the sentence that quotes it is usually where the problem lies. Authors are typically careful, and their limitations section is usually more cautious than anything written about them afterwards. A summary that omits the limitations is not necessarily wrong, but it is incomplete in a specific direction, and asking for the study rather than the summary resolves most of it.

Where each kind of claim tends to appear

Findings appear in studies, in regulatory documents and in guidance from professional bodies. Sentences about findings appear in material that has an interest in a conclusion. That does not make the second kind false, and it does mean the second kind is where checking pays off, because it is where a careful finding is most often stretched.

Claiming an open question is closed

A particular pattern is worth watching for, in both directions. Where the evidence cannot settle a question, a claim that it has been settled is a claim that is not supported, whichever way it goes. A sentence asserting that implants have been proven safe in every respect, and a sentence asserting that a causal link has been proven, are both unsupported by the same body of evidence. The accurate sentence is that some claims are established, some are unsupported, and the question in the middle is open.

Sentences that should slow a reader down

  • A claim of proof about a question the studies were not designed to answer.
  • A statistic quoted without its population, its period or its source.
  • A regulatory decision described as though it applied everywhere, or as though it settled the science.

None of this requires expertise. It requires asking what stands behind the sentence, and being willing to accept that the answer may be that the question is still open.

Related reading

Frequently asked questions

What should I ask about a safety claim?

What kind of study it comes from, who was studied and for how long, whether the sentence describes a finding or an absence of evidence, and who paid for the work. Those four questions separate most marketing sentences from most findings, and they can be asked by anyone without a clinical background.

Where do unsupported claims usually appear?

In material that has an interest in a conclusion: product pages, promotional content, and summaries that reduce a study to its most favourable sentence. Findings appear in the studies themselves, in regulatory documents and in guidance from professional bodies — sources that are usually less readable and considerably more careful.

How do I check a claim myself?

Ask for the study rather than the summary, and read what the authors say about the limitations, which is usually in the last section and is usually more cautious than the material that quoted them. For regulatory status, ask for the labelling or the approval document rather than a description of it.

Risks & Limitations

  • Breast implants are not lifetime devices, and a proportion will need removal or replacement at some point.
  • Rupture can occur without symptoms, which is why imaging surveillance is advised over time.
  • Capsular contracture is a recognised and labelled risk, and its cause is not fully understood.
  • Textured surfaces carry an established association with a rare lymphoma of the tissue around the implant.
  • A causal link between implants and systemic illness is not established by the evidence, and removal is not established as a cure for it.

When to Seek Care

  • A change in the shape or size of a breast, or a new lump — have it assessed by a clinician.
  • Swelling that comes and goes, or a fluid collection around an implant — have it assessed by a clinician.
  • Persistent pain or firmness around an implant, or a new and persistent symptom — have it assessed by a clinician.
  • Contact the service that holds your records, or the hospital’s outpatient channels, rather than relying on a website.

References & Further Reading

  • U.S. Food and Drug Administration (FDA) — approved breast implant labelling and safety communications
  • European Medicines Agency (EMA) and national regulators — breast implant assessment reports and restrictions
  • National Medical Products Administration (NMPA, China) — approved devices and their indications
  • World Health Organization (WHO) — classification of tumours of the breast, including implant-associated lymphoma
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.